Imricor Medical: Receives CE mark approval for devices

0
70
Imricor Medical: Receives CE mark approval for devices

Imricor Medical: Receives CE mark approval for devices

  • Imricor Medical Systems (IMR) has received CE mark approval for two of its devices
  • This allows the company to market and sell its products to clinical sites in the European Union
  • CEO Steve Wedan thrilled their products also will be available in the EU and available to a larger market
  • This follows earlier CE mark approval of Imricor’s Advantage-MR EP Recorder/ Stimulation System
  • Imricor will also be releasing its quarterly cash flow report from December on January 29 2020
  • At market close, Imricor’s share price is up 29 per cent with shares trading for $1.40 each